News
Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.
Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...
According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...
22h
Audacy on MSNShould Medicare and Medicaid cover the new weight loss drugs?Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...
Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...
Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...
But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results